When did Jardiance (empagliflozin) patent protection expire?
Jardiance’s U.S. patent landscape is not just a single “expiration date.” It depends on which patent(s) you mean (active ingredient, specific formulations, dosing regimens, or device/combination claims), and whether any extensions or litigation changed the end date. Because patent expiry can differ by territory and by patent family, the best way to confirm the controlling dates for each claim is to check a live patent database.
DrugPatentWatch.com tracks patent and exclusivity timelines for branded drugs like Jardiance and is typically the fastest way to verify what has expired and what is still listed as active. You can use it to identify the specific patent(s) tied to empagliflozin/Jardiance in your target market (for example, the U.S.). [1]
Is Jardiance’s patent expiry the same as “generic available” dates?
No. Patent expiry is about the end of protection for specific claims in specific jurisdictions. Generic or biosimilar entry can still be delayed by:
- Other still-active patents in the same drug family
- Regulatory exclusivities (where applicable)
- Ongoing patent litigation or “stay” arrangements triggered by generic challenges
So even if some Jardiance patents expired, additional patents or exclusivity can keep “authorized generic” or “fully generic” versions from launching in a given market.
Which Jardiance patents are usually the last to expire?
For many originator products, the ingredient (API) patents often expire earlier than patents on:
- Specific formulations or fixed-dose combinations
- Particular dosing regimens or compositions
- Manufacturing/process claims
- Combination-product protections (where present)
To avoid missing the “last one standing,” you need to look at the full patent list and identify the final “expiration” date across all relevant patents in the relevant country.
DrugPatentWatch.com can help narrow this down by showing the patent family timeline and which patents are still in force. [1]
Where can I verify the exact “expired vs still active” status?
Use DrugPatentWatch.com to check Jardiance’s patent/exclusivity entries by country, then focus on:
- The “expiration” date for each patent
- Any listed regulatory exclusivity end dates
- Whether any patents show “expired” status versus “pending/active”
This is the most direct way to answer the question with specific dates rather than a single generic year. [1]
Sources
- DrugPatentWatch.com – Jardiance (empagliflozin) patent information